• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多原发性癌症病例中的结直肠癌:59例临床特征及点突变分析

Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.

作者信息

Wu Anshan, He Siqi, Li Jingjing, Liu Ling, Liu Chunlan, Wang Qi, Peng Xiaowei, Zhou Jianda, Cao Pei-Guo, Cao Ke

机构信息

Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

Department of Plastic and Reconstructive Surgery, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

出版信息

Oncol Lett. 2017 Jun;13(6):4720-4726. doi: 10.3892/ol.2017.6097. Epub 2017 Apr 26.

DOI:10.3892/ol.2017.6097
PMID:28599473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5453044/
Abstract

The present study aimed to investigate the occurrence and clinical features of cases of multiple primary cancers including colorectal cancer (MPCC). The medical records of patients with colorectal cancer (CRC) who underwent surgery at the Third Xiangya Hospital of Central South University (Changsha, China) between August 2007 and August 2014 were retrospectively analyzed. Patients with MPCCs were identified and mutation analyses were performed on colon specimens. The results revealed that among 1,311 patients with CRC, 59 had MPCC (including 35 cases of ≥1 CRC with ≥1 other cancer type, and 24 cases with multiple CRCs and no other primary cancers). Foci occurred on the right side of the colon (n=32), in the rectum (n=28), and on the left side of the colon (n=24). MPCCs were synchronous in 24 patients, metachronous in 32 patients, and both in 3 patients. Age of onset and presence of polyps were identified as significantly different between MPCC and CRC overall (P<0.05); however, sex or adenoma incidence were not observed to differ significantly between groups. Mutation incidence rates in 26 specimens were 11.54% for KRAS proto-oncogene GTPase () G13D, 3.85% for Q61R and 3.85% B-Raf proto-oncogene serine/threonine kinase V600E. Mutations of exon 21 of the epithelial growth factor receptor gene, including L858R and L861Q, and of G12V were not detected. In conclusion, the likelihood of occurrence of MPCC is closely associated with the age of onset and the presence of polyp(s). Routine examination of multiple systems is necessary for patients with CRC to avoid missed diagnosis and misdiagnosis. Further study is required to demonstrate the molecular mechanism of CRC in cases of multiple primary cancers.

摘要

本研究旨在调查包括结直肠癌在内的多原发性癌症(MPCC)病例的发生情况及临床特征。对2007年8月至2014年8月期间在中南大学湘雅三医院(中国长沙)接受手术的结直肠癌(CRC)患者的病历进行回顾性分析。识别出MPCC患者,并对结肠标本进行突变分析。结果显示,在1311例CRC患者中,59例患有MPCC(包括35例≥1例CRC合并≥1种其他癌症类型,以及24例多发CRC且无其他原发性癌症)。病灶发生在结肠右侧(n = 32)、直肠(n = 28)和结肠左侧(n = 24)。MPCC在24例患者中为同时性,在32例患者中为异时性,在3例患者中两者皆有。总体而言,MPCC和CRC在发病年龄和息肉存在情况方面存在显著差异(P < 0.05);然而,未观察到两组在性别或腺瘤发生率方面有显著差异。26个标本中的突变发生率为:KRAS原癌基因GTP酶()G13D为11.54%,Q61R为3.85%,B-Raf原癌基因丝氨酸/苏氨酸激酶V600E为3.85%。未检测到上皮生长因子受体基因第21外显子的突变,包括L858R和L861Q以及G12V。总之,MPCC的发生可能性与发病年龄和息肉的存在密切相关。CRC患者需要对多个系统进行常规检查,以避免漏诊和误诊。需要进一步研究来阐明多原发性癌症病例中CRC的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/3868fc641e50/ol-13-06-4720-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/f2738a60c7ae/ol-13-06-4720-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/7f9569f1a8f8/ol-13-06-4720-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/3868fc641e50/ol-13-06-4720-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/f2738a60c7ae/ol-13-06-4720-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/7f9569f1a8f8/ol-13-06-4720-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fa/5453044/3868fc641e50/ol-13-06-4720-g02.jpg

相似文献

1
Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.多原发性癌症病例中的结直肠癌:59例临床特征及点突变分析
Oncol Lett. 2017 Jun;13(6):4720-4726. doi: 10.3892/ol.2017.6097. Epub 2017 Apr 26.
2
[Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].[中国结直肠癌患者KRAS和BRAF基因的突变:966例病例分析]
Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):579-83. doi: 10.3760/cma.j.issn.0529-5807.2012.09.002.
3
Demographic trends and KRAS/BRAF mutations in colorectal cancer patients of South China: A single-site report.中国南方结直肠癌患者的人口统计学趋势和 KRAS/BRAF 突变:单站点报告。
Int J Cancer. 2019 May 1;144(9):2109-2117. doi: 10.1002/ijc.31973. Epub 2019 Feb 5.
4
Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.与结直肠癌和/或息肉家族史相关的锯齿状息肉病:息肉在结肠和直肠中的优先位置定义了两个分子实体。
Int J Mol Med. 2016 Sep;38(3):687-702. doi: 10.3892/ijmm.2016.2666. Epub 2016 Jul 5.
5
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.联合分析 KRAS 特定突变、BRAF 和微卫星不稳定性可识别散发性和遗传性结直肠癌的预后亚组。
Int J Cancer. 2010 Dec 1;127(11):2569-75. doi: 10.1002/ijc.25265.
6
Clinical characteristics of multiple primary colorectal cancers.多原发结直肠癌的临床特征。
Cancer Res Treat. 2008 Jun;40(2):71-4. doi: 10.4143/crt.2008.40.2.71. Epub 2008 Jun 30.
7
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.KRAS和BRAF中的伴随突变及剪接变体表明晚期结直肠癌中Ras/Raf信号通路存在复杂的扰动。
Gut. 2009 Sep;58(9):1234-41. doi: 10.1136/gut.2008.159137. Epub 2009 May 26.
8
Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.结肠和直肠增生性息肉——重新分类、索引息肉及后续结直肠癌中的BRAF和KRAS状态
APMIS. 2015 Apr;123(4):298-304. doi: 10.1111/apm.12355. Epub 2015 Feb 23.
9
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.KRas G12V 比 KRas G13D 在结直肠癌模型中的转移效率更高。
FASEB J. 2015 Feb;29(2):464-76. doi: 10.1096/fj.14-262303. Epub 2014 Oct 30.
10
Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?同时性和异时性结直肠癌:不同的疾病实体还是不同的疾病进程?
Hepatogastroenterology. 2015 Jun;62(140):838-42.

引用本文的文献

1
Synchronous Colorectal and Prostate Cancer: Dual PET/CT Approach for Detecting and Distinguishing Metastatic Patterns.同步性结直肠癌和前列腺癌:采用双PET/CT方法检测和区分转移模式
Nucl Med Mol Imaging. 2023 Dec;57(6):291-294. doi: 10.1007/s13139-023-00812-7. Epub 2023 Jul 6.
2
Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.血浆甲基化 SEPT9 作为一种新型生物标志物用于预测结直肠癌肝转移。
Mol Biotechnol. 2024 Sep;66(9):2254-2261. doi: 10.1007/s12033-023-00855-3. Epub 2023 Aug 23.
3
Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database.

本文引用的文献

1
Prognostic impact of mutation profiling in patients with stage II and III colon cancer.Ⅱ期和Ⅲ期结肠癌患者突变分析的预后影响。
Sci Rep. 2016 Apr 14;6:24310. doi: 10.1038/srep24310.
2
Young patients with colorectal cancer have increased risk of second primary cancers.患有结直肠癌的年轻患者患第二原发性癌症的风险增加。
Jpn J Clin Oncol. 2015 Nov;45(11):1029-35. doi: 10.1093/jjco/hyv137. Epub 2015 Sep 18.
3
Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.下一代测序在结直肠癌临床突变检测中的性能特征
基于监测、流行病学和最终结果(SEER)数据库开发预测同步性多原发性结直肠癌总生存期和癌症特异性生存期的预后列线图。
J Cancer Res Clin Oncol. 2023 Nov;149(15):14057-14070. doi: 10.1007/s00432-023-05221-z. Epub 2023 Aug 7.
4
Genetic characteristics of a patient with multiple primary cancers: A case report.一名多原发性癌症患者的遗传特征:病例报告。
World J Clin Cases. 2021 Oct 6;9(28):8563-8570. doi: 10.12998/wjcc.v9.i28.8563.
5
Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference.多原发性结直肠癌患者预后的回顾性研究:同时性与异时性的差异
Int J Colorectal Dis. 2021 Jul;36(7):1487-1498. doi: 10.1007/s00384-021-03926-6. Epub 2021 Apr 14.
6
The Rare Diagnosis of Synchronous Breast and Colonic Cancers: A Case Report and Review of Literature.同步性乳腺癌和结肠癌的罕见诊断:一例报告及文献综述
Cureus. 2021 Feb 12;13(2):e13314. doi: 10.7759/cureus.13314.
7
Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.同步和异时性多原发结直肠癌的临床病理特征和预后。
Clin Transl Oncol. 2021 Feb;23(2):335-343. doi: 10.1007/s12094-020-02426-3. Epub 2020 Jun 26.
8
A Rare Occurrence of Three Primary Malignancies of the Rectum, Breast, and Kidney in the Same Patient: A Case Report and Review of the Literature.同一患者罕见地出现直肠、乳腺和肾脏原发性恶性肿瘤:病例报告及文献综述
Case Rep Surg. 2019 Sep 9;2019:1716029. doi: 10.1155/2019/1716029. eCollection 2019.
9
Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report.靶向测序鉴定双原发和转移恶性肿瘤的突变特征:病例报告。
Diagn Pathol. 2019 Sep 4;14(1):101. doi: 10.1186/s13000-019-0874-5.
10
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.中国结直肠癌患者术前甲基化 septin 9 的临床价值。
World J Gastroenterol. 2019 May 7;25(17):2099-2109. doi: 10.3748/wjg.v25.i17.2099.
Mod Pathol. 2015 Oct;28(10):1390-9. doi: 10.1038/modpathol.2015.86. Epub 2015 Jul 31.
4
Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique.通过质谱法检测KRAS、NRAS和BRAF——一种灵敏、可靠、快速且经济高效的技术。
Diagn Pathol. 2015 Jul 30;10:132. doi: 10.1186/s13000-015-0364-3.
5
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).韩国队列(1993 - 2010年)中头颈部癌后异时性第二原发性恶性肿瘤
PLoS One. 2015 Jul 28;10(7):e0134160. doi: 10.1371/journal.pone.0134160. eCollection 2015.
6
Current knowledge and future research directions in treatment-related second primary malignancies.治疗相关的第二原发性恶性肿瘤的当前知识与未来研究方向。
EJC Suppl. 2014 Jun;12(1):5-17. doi: 10.1016/j.ejcsup.2014.05.001. Epub 2014 May 29.
7
Annual report on status of cancer in China, 2011.《2011年中国癌症现状年度报告》
Chin J Cancer Res. 2015 Feb;27(1):2-12. doi: 10.3978/j.issn.1000-9604.2015.01.06.
8
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.上皮-间质转化(EMT)标志物对多发性原发性口腔鳞状细胞癌具有预后影响。
Clin Exp Metastasis. 2015 Jan;32(1):55-63. doi: 10.1007/s10585-014-9690-1. Epub 2014 Nov 30.
9
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
10
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.希腊和罗马尼亚结直肠癌患者的KRAS、NRAS和BRAF基因突变:一项队列研究。
BMJ Open. 2014 May 23;4(5):e004652. doi: 10.1136/bmjopen-2013-004652.